APO Research
Talk to an analyst

APO RESEARCH · REPORT

Inhalation Sevoflurane Anaesthetic Agent

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Inhalation Sevoflurane Anaesthetic Agent Market Outlook and Growth Opportunities 2026

2 January 2026198 pages

Choose your research edition.

Industry ResearchInhalation Sevoflurane Anaesthetic Agent Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Inhalation Sevoflurane Anaesthetic Agent Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Inhalation Sevoflurane Anaesthetic Agent Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Inhalation Sevoflurane Anaesthetic Agent Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Inhalation Sevoflurane Anaesthetic Agent Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Inhalation Sevoflurane Anaesthetic Agent market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Inhalation Sevoflurane Anaesthetic Agent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Inhalation Sevoflurane Anaesthetic Agent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Inhalation Sevoflurane Anaesthetic Agent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Inhalation Sevoflurane Anaesthetic Agent market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Inhalation Sevoflurane Anaesthetic Agent market include Maruishi, Piramal, PT Novell Pharmaceutical, Viatris, AbbVie and Baxter, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Inhalation Sevoflurane Anaesthetic Agent market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Inhalation Sevoflurane Anaesthetic Agent and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Inhalation Sevoflurane Anaesthetic Agent sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Inhalation Sevoflurane Anaesthetic Agent market size, projected growth trends, production technologies, key applications, and end-use industries.

Inhalation Sevoflurane Anaesthetic Agent Segment by Company

Maruishi

Piramal

PT Novell Pharmaceutical

Viatris

AbbVie

Baxter

Inhalation Sevoflurane Anaesthetic Agent Segment by Type

250ml/Bottle

120ml/Bottle

Other

Inhalation Sevoflurane Anaesthetic Agent Segment by Application

Hospital

Clinics

Other

Inhalation Sevoflurane Anaesthetic Agent Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Inhalation Sevoflurane Anaesthetic Agent status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Inhalation Sevoflurane Anaesthetic Agent market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Inhalation Sevoflurane Anaesthetic Agent significant trends, drivers, influence factors in global and regions.

6. To analyze Inhalation Sevoflurane Anaesthetic Agent competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Inhalation Sevoflurane Anaesthetic Agent market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Inhalation Sevoflurane Anaesthetic Agent and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Inhalation Sevoflurane Anaesthetic Agent.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Inhalation Sevoflurane Anaesthetic Agent market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Inhalation Sevoflurane Anaesthetic Agent industry.

Chapter 3: Detailed analysis of Inhalation Sevoflurane Anaesthetic Agent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Inhalation Sevoflurane Anaesthetic Agent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Inhalation Sevoflurane Anaesthetic Agent in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Inhalation Sevoflurane Anaesthetic Agent Industry Trends Table 2. Inhalation Sevoflurane Anaesthetic Agent Industry Drivers Table 3. Inhalation Sevoflurane Anaesthetic Agent Industry Opportunities and Challenges Table 4. Inhalation Sevoflurane Anaesthetic Agent Industry Restraints Table 5. Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Share by Company (2021-2026) Table 7. Global Inhalation Sevoflurane Anaesthetic Agent Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Inhalation Sevoflurane Anaesthetic Agent Sales Volume Share by Company (2021-2026) Table 9. Global Inhalation Sevoflurane Anaesthetic Agent Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Inhalation Sevoflurane Anaesthetic Agent Company Ranking, (2024-2026) & (USD Million) Table 11. Global Inhalation Sevoflurane Anaesthetic Agent Key Company Manufacturing Base & Headquarters Table 12. Global Inhalation Sevoflurane Anaesthetic Agent Company, Product Type & Application Table 13. Global Inhalation Sevoflurane Anaesthetic Agent Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Inhalation Sevoflurane Anaesthetic Agent by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 250ml/Bottle Table 18. Significant Companies of 120ml/Bottle Table 19. Significant Companies of Other Table 20. Global Inhalation Sevoflurane Anaesthetic Agent Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Inhalation Sevoflurane Anaesthetic Agent Sales Volume by Type (2021-2026) & (K Units) Table 22. Global Inhalation Sevoflurane Anaesthetic Agent Sales Volume by Type (2027-2032) & (K Units) Table 23. Global Inhalation Sevoflurane Anaesthetic Agent Sales Volume Share by Type (2021-2026) Table 24. Global Inhalation Sevoflurane Anaesthetic Agent Sales Volume Share by Type (2027-2032) Table 25. Global Inhalation Sevoflurane Anaesthetic Agent Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Inhalation Sevoflurane Anaesthetic Agent Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Inhalation Sevoflurane Anaesthetic Agent Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Type (2021-2026) Table 29. Global Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Hospital Table 31. Significant Companies of Clinics Table 32. Significant Companies of Other Table 33. Global Inhalation Sevoflurane Anaesthetic Agent Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Inhalation Sevoflurane Anaesthetic Agent Sales Volume by Application (2021-2026) & (K Units) Table 35. Global Inhalation Sevoflurane Anaesthetic Agent Sales Volume by Application (2027-2032) & (K Units) Table 36. Global Inhalation Sevoflurane Anaesthetic Agent Sales Volume Share by Application (2021-2026) Table 37. Global Inhalation Sevoflurane Anaesthetic Agent Sales Volume Share by Application (2027-2032) Table 38. Global Inhalation Sevoflurane Anaesthetic Agent Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Inhalation Sevoflurane Anaesthetic Agent Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Inhalation Sevoflurane Anaesthetic Agent Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Application (2021-2026) Table 42. Global Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Application (2027-2032) Table 43. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Region (2021-2026) & (K Units) Table 45. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Region (2021-2026) Table 46. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Region (2027-2032) & (K Units) Table 47. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Region (2027-2032) Table 48. Global Inhalation Sevoflurane Anaesthetic Agent Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Inhalation Sevoflurane Anaesthetic Agent Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Region (2021-2026) Table 51. Global Inhalation Sevoflurane Anaesthetic Agent Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Region (2027-2032) Table 53. Global Inhalation Sevoflurane Anaesthetic Agent Market Average Price (US$/Unit) by Region (2021-2026) Table 54. Global Inhalation Sevoflurane Anaesthetic Agent Market Average Price (US$/Unit) by Region (2027-2032) Table 55. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Global Inhalation Sevoflurane Anaesthetic Agent Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2021-2026) & (K Units) Table 58. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Country (2021-2026) Table 59. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2027-2032) & (K Units) Table 60. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Country (2027-2032) Table 61. Global Inhalation Sevoflurane Anaesthetic Agent Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Inhalation Sevoflurane Anaesthetic Agent Sales Value Market Share by Country (2021-2026) Table 63. Global Inhalation Sevoflurane Anaesthetic Agent Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Inhalation Sevoflurane Anaesthetic Agent Sales Value Market Share by Country (2027-2032) Table 65. Maruishi Company Information Table 66. Maruishi Business Overview Table 67. Maruishi Inhalation Sevoflurane Anaesthetic Agent Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Maruishi Inhalation Sevoflurane Anaesthetic Agent Product Portfolio Table 69. Maruishi Recent Development Table 70. Piramal Company Information Table 71. Piramal Business Overview Table 72. Piramal Inhalation Sevoflurane Anaesthetic Agent Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Piramal Inhalation Sevoflurane Anaesthetic Agent Product Portfolio Table 74. Piramal Recent Development Table 75. PT Novell Pharmaceutical Company Information Table 76. PT Novell Pharmaceutical Business Overview Table 77. PT Novell Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. PT Novell Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Product Portfolio Table 79. PT Novell Pharmaceutical Recent Development Table 80. Viatris Company Information Table 81. Viatris Business Overview Table 82. Viatris Inhalation Sevoflurane Anaesthetic Agent Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Viatris Inhalation Sevoflurane Anaesthetic Agent Product Portfolio Table 84. Viatris Recent Development Table 85. AbbVie Company Information Table 86. AbbVie Business Overview Table 87. AbbVie Inhalation Sevoflurane Anaesthetic Agent Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. AbbVie Inhalation Sevoflurane Anaesthetic Agent Product Portfolio Table 89. AbbVie Recent Development Table 90. Baxter Company Information Table 91. Baxter Business Overview Table 92. Baxter Inhalation Sevoflurane Anaesthetic Agent Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Baxter Inhalation Sevoflurane Anaesthetic Agent Product Portfolio Table 94. Baxter Recent Development Table 95. Key Raw Materials Table 96. Raw Materials Key Suppliers Table 97. Inhalation Sevoflurane Anaesthetic Agent Distributors List Table 98. Inhalation Sevoflurane Anaesthetic Agent Customers List Table 99. Research Programs/Design for This Report Table 100. Authors List of This Report Table 101. Secondary Sources Table 102. Primary Sources List of Figures Figure 1. Inhalation Sevoflurane Anaesthetic Agent Product Image Figure 2. Global Inhalation Sevoflurane Anaesthetic Agent Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Inhalation Sevoflurane Anaesthetic Agent Sales Value (2021-2032) & (US$ Million) Figure 4. Global Inhalation Sevoflurane Anaesthetic Agent Sales (2021-2032) & (K Units) Figure 5. Global Inhalation Sevoflurane Anaesthetic Agent Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Inhalation Sevoflurane Anaesthetic Agent Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 250ml/Bottle Image Figure 10. 120ml/Bottle Image Figure 11. Other Image Figure 12. Global Inhalation Sevoflurane Anaesthetic Agent Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Inhalation Sevoflurane Anaesthetic Agent Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Inhalation Sevoflurane Anaesthetic Agent Sales Volume Share by Type (2021-2032) Figure 15. Global Inhalation Sevoflurane Anaesthetic Agent Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Inhalation Sevoflurane Anaesthetic Agent Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Type (2021-2032) Figure 18. Hospital Image Figure 19. Clinics Image Figure 20. Other Image Figure 21. Global Inhalation Sevoflurane Anaesthetic Agent Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Inhalation Sevoflurane Anaesthetic Agent Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Inhalation Sevoflurane Anaesthetic Agent Sales Volume Share by Application (2021-2032) Figure 24. Global Inhalation Sevoflurane Anaesthetic Agent Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Inhalation Sevoflurane Anaesthetic Agent Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Application (2021-2032) Figure 27. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 28. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Inhalation Sevoflurane Anaesthetic Agent Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Inhalation Sevoflurane Anaesthetic Agent Sales Value (2021-2032) & (US$ Million) Figure 32. North America Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Inhalation Sevoflurane Anaesthetic Agent Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Inhalation Sevoflurane Anaesthetic Agent Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Inhalation Sevoflurane Anaesthetic Agent Sales Value (2021-2032) & (US$ Million) Figure 38. South America Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Inhalation Sevoflurane Anaesthetic Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Inhalation Sevoflurane Anaesthetic Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Inhalation Sevoflurane Anaesthetic Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Inhalation Sevoflurane Anaesthetic Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Inhalation Sevoflurane Anaesthetic Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Inhalation Sevoflurane Anaesthetic Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Inhalation Sevoflurane Anaesthetic Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Inhalation Sevoflurane Anaesthetic Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Inhalation Sevoflurane Anaesthetic Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Inhalation Sevoflurane Anaesthetic Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Inhalation Sevoflurane Anaesthetic Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Inhalation Sevoflurane Anaesthetic Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Inhalation Sevoflurane Anaesthetic Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Inhalation Sevoflurane Anaesthetic Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Inhalation Sevoflurane Anaesthetic Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Inhalation Sevoflurane Anaesthetic Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Inhalation Sevoflurane Anaesthetic Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Inhalation Sevoflurane Anaesthetic Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Inhalation Sevoflurane Anaesthetic Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Inhalation Sevoflurane Anaesthetic Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Inhalation Sevoflurane Anaesthetic Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Inhalation Sevoflurane Anaesthetic Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Inhalation Sevoflurane Anaesthetic Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Inhalation Sevoflurane Anaesthetic Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Inhalation Sevoflurane Anaesthetic Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Inhalation Sevoflurane Anaesthetic Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Inhalation Sevoflurane Anaesthetic Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Inhalation Sevoflurane Anaesthetic Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Inhalation Sevoflurane Anaesthetic Agent Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Inhalation Sevoflurane Anaesthetic Agent Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • 250ml/Bottle
  • 120ml/Bottle
  • Other
Applications
  • Hospital
  • Clinics
  • Other
Companies covered
  • Maruishi
  • Piramal
  • PT Novell Pharmaceutical
  • Viatris
  • AbbVie
  • Baxter

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Inhalation Sevoflurane Anaesthetic Agent Sales Value (2021-2032)
  4. 1.2.2 Global Inhalation Sevoflurane Anaesthetic Agent Sales Volume (2021-2032)
  5. 1.2.3 Global Inhalation Sevoflurane Anaesthetic Agent Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Inhalation Sevoflurane Anaesthetic Agent Market Dynamics
  1. 2.1 Inhalation Sevoflurane Anaesthetic Agent Industry Trends
  2. 2.2 Inhalation Sevoflurane Anaesthetic Agent Industry Drivers
  3. 2.3 Inhalation Sevoflurane Anaesthetic Agent Industry Opportunities and Challenges
  4. 2.4 Inhalation Sevoflurane Anaesthetic Agent Industry Restraints
3 Inhalation Sevoflurane Anaesthetic Agent Market by Company
  1. 3.1 Global Inhalation Sevoflurane Anaesthetic Agent Company Revenue Ranking in 2025
  2. 3.2 Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Company (2021-2026)
  3. 3.3 Global Inhalation Sevoflurane Anaesthetic Agent Sales Volume by Company (2021-2026)
  4. 3.4 Global Inhalation Sevoflurane Anaesthetic Agent Average Price by Company (2021-2026)
  5. 3.5 Global Inhalation Sevoflurane Anaesthetic Agent Company Ranking (2024-2026)
  6. 3.6 Global Inhalation Sevoflurane Anaesthetic Agent Company Manufacturing Base and Headquarters
  7. 3.7 Global Inhalation Sevoflurane Anaesthetic Agent Company Product Type and Application
  8. 3.8 Global Inhalation Sevoflurane Anaesthetic Agent Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Inhalation Sevoflurane Anaesthetic Agent Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Inhalation Sevoflurane Anaesthetic Agent Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Inhalation Sevoflurane Anaesthetic Agent Market by Type
  1. 4.1 Inhalation Sevoflurane Anaesthetic Agent Type Introduction
  2. 4.1.1 250ml/Bottle
  3. 4.1.2 120ml/Bottle
  4. 4.1.3 Other
  5. 4.2 Global Inhalation Sevoflurane Anaesthetic Agent Sales Volume by Type
  6. 4.2.1 Global Inhalation Sevoflurane Anaesthetic Agent Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Inhalation Sevoflurane Anaesthetic Agent Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Inhalation Sevoflurane Anaesthetic Agent Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Inhalation Sevoflurane Anaesthetic Agent Sales Value by Type
  10. 4.3.1 Global Inhalation Sevoflurane Anaesthetic Agent Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Inhalation Sevoflurane Anaesthetic Agent Sales Value by Type (2021-2032)
  12. 4.3.3 Global Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Type (2021-2032)
5 Inhalation Sevoflurane Anaesthetic Agent Market by Application
  1. 5.1 Inhalation Sevoflurane Anaesthetic Agent Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinics
  4. 5.1.3 Other
  5. 5.2 Global Inhalation Sevoflurane Anaesthetic Agent Sales Volume by Application
  6. 5.2.1 Global Inhalation Sevoflurane Anaesthetic Agent Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Inhalation Sevoflurane Anaesthetic Agent Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Inhalation Sevoflurane Anaesthetic Agent Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Inhalation Sevoflurane Anaesthetic Agent Sales Value by Application
  10. 5.3.1 Global Inhalation Sevoflurane Anaesthetic Agent Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Inhalation Sevoflurane Anaesthetic Agent Sales Value by Application (2021-2032)
  12. 5.3.3 Global Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Application (2021-2032)
6 Inhalation Sevoflurane Anaesthetic Agent Regional Sales and Value Analysis
  1. 6.1 Global Inhalation Sevoflurane Anaesthetic Agent Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Inhalation Sevoflurane Anaesthetic Agent Sales by Region (2021-2032)
  3. 6.2.1 Global Inhalation Sevoflurane Anaesthetic Agent Sales by Region: 2021-2026
  4. 6.2.2 Global Inhalation Sevoflurane Anaesthetic Agent Sales by Region (2027-2032)
  5. 6.3 Global Inhalation Sevoflurane Anaesthetic Agent Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Inhalation Sevoflurane Anaesthetic Agent Sales Value by Region (2021-2032)
  7. 6.4.1 Global Inhalation Sevoflurane Anaesthetic Agent Sales Value by Region: 2021-2026
  8. 6.4.2 Global Inhalation Sevoflurane Anaesthetic Agent Sales Value by Region (2027-2032)
  9. 6.5 Global Inhalation Sevoflurane Anaesthetic Agent Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Inhalation Sevoflurane Anaesthetic Agent Sales Value (2021-2032)
  12. 6.6.2 North America Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Inhalation Sevoflurane Anaesthetic Agent Sales Value (2021-2032)
  15. 6.7.2 Europe Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Inhalation Sevoflurane Anaesthetic Agent Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Inhalation Sevoflurane Anaesthetic Agent Sales Value (2021-2032)
  21. 6.9.2 South America Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Country, 2025 VS 2032
7 Inhalation Sevoflurane Anaesthetic Agent Country-level Sales and Value Analysis
  1. 7.1 Global Inhalation Sevoflurane Anaesthetic Agent Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Inhalation Sevoflurane Anaesthetic Agent Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2021-2032)
  4. 7.3.1 Global Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2021-2026)
  5. 7.3.2 Global Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2027-2032)
  6. 7.4 Global Inhalation Sevoflurane Anaesthetic Agent Sales Value by Country (2021-2032)
  7. 7.4.1 Global Inhalation Sevoflurane Anaesthetic Agent Sales Value by Country (2021-2026)
  8. 7.4.2 Global Inhalation Sevoflurane Anaesthetic Agent Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Inhalation Sevoflurane Anaesthetic Agent Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Inhalation Sevoflurane Anaesthetic Agent Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Inhalation Sevoflurane Anaesthetic Agent Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Inhalation Sevoflurane Anaesthetic Agent Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Inhalation Sevoflurane Anaesthetic Agent Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Inhalation Sevoflurane Anaesthetic Agent Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Inhalation Sevoflurane Anaesthetic Agent Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Inhalation Sevoflurane Anaesthetic Agent Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Inhalation Sevoflurane Anaesthetic Agent Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Inhalation Sevoflurane Anaesthetic Agent Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Inhalation Sevoflurane Anaesthetic Agent Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Inhalation Sevoflurane Anaesthetic Agent Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Inhalation Sevoflurane Anaesthetic Agent Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Inhalation Sevoflurane Anaesthetic Agent Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Inhalation Sevoflurane Anaesthetic Agent Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Inhalation Sevoflurane Anaesthetic Agent Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Inhalation Sevoflurane Anaesthetic Agent Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Inhalation Sevoflurane Anaesthetic Agent Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Inhalation Sevoflurane Anaesthetic Agent Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Inhalation Sevoflurane Anaesthetic Agent Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Inhalation Sevoflurane Anaesthetic Agent Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Inhalation Sevoflurane Anaesthetic Agent Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Inhalation Sevoflurane Anaesthetic Agent Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Inhalation Sevoflurane Anaesthetic Agent Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Inhalation Sevoflurane Anaesthetic Agent Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Inhalation Sevoflurane Anaesthetic Agent Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Inhalation Sevoflurane Anaesthetic Agent Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Inhalation Sevoflurane Anaesthetic Agent Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Inhalation Sevoflurane Anaesthetic Agent Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Maruishi
  2. 8.1.1 Maruishi Company Information
  3. 8.1.2 Maruishi Business Overview
  4. 8.1.3 Maruishi Inhalation Sevoflurane Anaesthetic Agent Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Maruishi Inhalation Sevoflurane Anaesthetic Agent Product Portfolio
  6. 8.1.5 Maruishi Recent Developments
  7. 8.2 Piramal
  8. 8.2.1 Piramal Company Information
  9. 8.2.2 Piramal Business Overview
  10. 8.2.3 Piramal Inhalation Sevoflurane Anaesthetic Agent Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Piramal Inhalation Sevoflurane Anaesthetic Agent Product Portfolio
  12. 8.2.5 Piramal Recent Developments
  13. 8.3 PT Novell Pharmaceutical
  14. 8.3.1 PT Novell Pharmaceutical Company Information
  15. 8.3.2 PT Novell Pharmaceutical Business Overview
  16. 8.3.3 PT Novell Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 PT Novell Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Product Portfolio
  18. 8.3.5 PT Novell Pharmaceutical Recent Developments
  19. 8.4 Viatris
  20. 8.4.1 Viatris Company Information
  21. 8.4.2 Viatris Business Overview
  22. 8.4.3 Viatris Inhalation Sevoflurane Anaesthetic Agent Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Viatris Inhalation Sevoflurane Anaesthetic Agent Product Portfolio
  24. 8.4.5 Viatris Recent Developments
  25. 8.5 AbbVie
  26. 8.5.1 AbbVie Company Information
  27. 8.5.2 AbbVie Business Overview
  28. 8.5.3 AbbVie Inhalation Sevoflurane Anaesthetic Agent Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 AbbVie Inhalation Sevoflurane Anaesthetic Agent Product Portfolio
  30. 8.5.5 AbbVie Recent Developments
  31. 8.6 Baxter
  32. 8.6.1 Baxter Company Information
  33. 8.6.2 Baxter Business Overview
  34. 8.6.3 Baxter Inhalation Sevoflurane Anaesthetic Agent Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Baxter Inhalation Sevoflurane Anaesthetic Agent Product Portfolio
  36. 8.6.5 Baxter Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Inhalation Sevoflurane Anaesthetic Agent Value Chain Analysis
  2. 9.1.1 Inhalation Sevoflurane Anaesthetic Agent Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Inhalation Sevoflurane Anaesthetic Agent Sales Mode & Process
  6. 9.2 Inhalation Sevoflurane Anaesthetic Agent Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Inhalation Sevoflurane Anaesthetic Agent Distributors
  9. 9.2.3 Inhalation Sevoflurane Anaesthetic Agent Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst